Condition: Gastrointestinal Cancer · Sponsor: Merck Sharp & Dohme LLC
Researchers want to learn if patritumab deruxtecan (MK-1022) can treat certain gastrointestinal (GI) cancers. The GI cancers being studied are advanced (the cancer has spread to other parts of the body). The goals of this study are to learn: * About the safety and how well people tolerate of patritumab deruxtecan * How many people have the cancer respond (get smaller or go away) to treatment
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| UCLA Hematology Oncology Santa Monica ( Site 1205) | Santa Monica, California, United States | Active Not Recruiting |
| University of Colorado Cancer Center ( Site 1200) | Aurora, Colorado, United States | Recruiting |
| Sibley Memorial Hospital ( Site 1208) | Washington D.C., District of Columbia, United States | Recruiting |
| University of Florida ( Site 1202) | Gainesville, Florida, United States | Recruiting |
| Mount Sinai Medical Center Comprehensive Cancer Center ( Site 1213) | Miami Beach, Florida, United States | Recruiting |
| Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 1203) | Marietta, Georgia, United States | Completed |
| University of Chicago Medical Center ( Site 1204) | Chicago, Illinois, United States | Recruiting |
| Renown Regional Medical Center ( Site 1221) | Reno, Nevada, United States | Active Not Recruiting |
| NYU Langone Hospital - Long Island ( Site 1230) | Mineola, New York, United States | Completed |
| Perlmutter NYU Cancer Center ( Site 1212) | New York, New York, United States | Completed |
| Scott & White Medical Center-Temple ( Site 1224) | Temple, Texas, United States | Recruiting |
| Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 1207) | Roanoke, Virginia, United States | Recruiting |
+ 50 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06596694